Skip to main content
Top
Published in: Diabetologia 2/2004

01-02-2004 | Observation

SNP3 polymorphism in apo A-V gene is associated with small dense LDL particles in Type 2 diabetes

Authors: E. Esteve, E. Faure, F. Calvo, E. Aguillo, C. Blasco, M. J. Roche, P. Mozas, M. Pocovi

Published in: Diabetologia | Issue 2/2004

Login to get access

Excerpt

To the Editor: The −1131 T>C (SNP3) polymorphism of apo A-V gene has been associated in some studies to an increase in triglycerides and in few cases to a decrease in HDL-cholesterol. Its frequency is 12% in Afro-Americans, 16% in Hispanics, 6 to 16% in Caucasians and 7% in a Spanish control cohort [1, 2, 3, 4]. The heterozygote subjects for rare SNP3 allele (C/T) are related to an increase in triglycerides in Hispanic and Caucasian men, although these data were not observed in another study where the increase in triglycerides was only statistically significant in homozygotes for the mutated allele [3]. Hypertriglyceridaemia is the main factor in determining the size of the LDL. There are many causes that influence the metabolism of triglycerides, some are primary, such as the apo E genotype, and others secondary. Type 2 diabetes mellitus is linked to different lipid disorders such as hypertriglyceridaemia, a decrease in HDL-cholesterol and an increase in small, dense LDL. …
Literature
1.
go back to reference Pennacchio LA, Olivier M, Hubacek JA et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169–173PubMed Pennacchio LA, Olivier M, Hubacek JA et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169–173PubMed
2.
go back to reference Pennachio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031–3038CrossRefPubMed Pennachio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031–3038CrossRefPubMed
3.
go back to reference Talmud PJ, Hawe E, Martin S et al. (2002) Relative contribution of variation within the APO C3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11:3039–3046CrossRefPubMed Talmud PJ, Hawe E, Martin S et al. (2002) Relative contribution of variation within the APO C3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11:3039–3046CrossRefPubMed
4.
go back to reference Ribalta J, Figuera L, Fernández-Ballart J et al. (2002) Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 48:1597–1600PubMed Ribalta J, Figuera L, Fernández-Ballart J et al. (2002) Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 48:1597–1600PubMed
5.
go back to reference Sánchez-Quesada JL, Pérez A, Caixas A, Ordóñez-Llanos J, Carreras G, Payes A (1996) Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycemic control. Diabetologia 39:1469–1476 Sánchez-Quesada JL, Pérez A, Caixas A, Ordóñez-Llanos J, Carreras G, Payes A (1996) Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycemic control. Diabetologia 39:1469–1476
6.
go back to reference Iglesias A, Contreras JA, Martínez-Pardo M, Entrala A, Herrera E, Lasuncion MA (1993) Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias. Clin Chim Acta 221:73–89CrossRefPubMed Iglesias A, Contreras JA, Martínez-Pardo M, Entrala A, Herrera E, Lasuncion MA (1993) Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias. Clin Chim Acta 221:73–89CrossRefPubMed
7.
go back to reference Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548PubMed Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548PubMed
8.
go back to reference Haffner SM, Mykkanen L, Valdez RA, Paidi M, Stern MP, Howard BV (1993) LDL size and subclass pattern in a biethnic population. Arterioscler Thromb 13:1623–1630PubMed Haffner SM, Mykkanen L, Valdez RA, Paidi M, Stern MP, Howard BV (1993) LDL size and subclass pattern in a biethnic population. Arterioscler Thromb 13:1623–1630PubMed
Metadata
Title
SNP3 polymorphism in apo A-V gene is associated with small dense LDL particles in Type 2 diabetes
Authors
E. Esteve
E. Faure
F. Calvo
E. Aguillo
C. Blasco
M. J. Roche
P. Mozas
M. Pocovi
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1308-0

Other articles of this Issue 2/2004

Diabetologia 2/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine